IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cyclacel Pharmaceuticals Inc

CUSIP: 23254L603 | 65 institutional holders

Quarters

Q4 2024Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2024

VSM Wealth Advisory, LLC4,935
0.0% of portfolio›$36.0K
StyleTurnoverLocationFiled
VSM Wealth Advisory, LLC
4,935$36.0K0.0%ETFMediumHunt Valley, MD2025-02-11